B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides.
about
Bruton's tyrosine kinase (BTK) inhibitors in clinical trials.Tissue biomarkers of drug efficacy: case studies using a MALDI-MSI workflow.Targeting Bruton's tyrosine kinase signaling as an emerging therapeutic agent of B-cell malignanciesBruton tyrosine kinase inhibitor ibrutinib (PCI-32765).Oncogenic properties of sphingosine kinases in haematological malignancies.Increased ceramide production sensitizes breast cancer cell response to chemotherapy.Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6.Effect of CAL-101, a PI3Kδ inhibitor, on ribosomal rna synthesis and cell proliferation in acute myeloid leukemia cells.miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL.MicroRNA-155 regulates casein kinase 1 gamma 2: a potential pathogenetic role in chronic lymphocytic leukemia.Feeding Angptl4-/- mice trans fat promotes foam cell formation in mesenteric lymph nodes without leading to ascites.Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression.STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemiaFludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia
P2860
Q34039406-52457295-4E71-4C8F-AEAD-C165A054B903Q35822736-818574C4-1783-40C2-A2F8-0EEDE80A8A54Q36334833-0BA1BADD-2387-4F27-9A85-E0D34E73317FQ38083077-6F27342D-B3E8-4594-9E23-CBB8F58BD9A8Q38092176-E5A8E8D7-EB71-48C6-A0D7-DE7AA341E853Q38709652-6FE02D5A-4FB0-4F49-B5CC-138D8FB2D538Q39251334-500CAB46-703D-4902-AE44-7F8E7FD2433FQ42974476-F4008923-B711-4803-922C-6F6AD85DE7F6Q43162081-936077E3-3637-42A4-83BE-077BC9E597D6Q49837339-B366F445-E92C-4E30-8793-C9E25A8D22B7Q51056126-EACDD17E-54C6-4FD2-810D-36AA2B0700F8Q54943815-7EA9D67A-6CC4-4F7C-B4FA-B1BF86F52711Q56481251-DDE80A94-D97B-4AAC-A28A-8D812EAF0A0CQ58764409-F75FAB00-F3C6-430F-BE56-9A65D76422ED
P2860
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
B-cell receptor triggers drug ...... ng glucosylation of ceramides.
@en
B-cell receptor triggers drug ...... ng glucosylation of ceramides.
@nl
type
label
B-cell receptor triggers drug ...... ng glucosylation of ceramides.
@en
B-cell receptor triggers drug ...... ng glucosylation of ceramides.
@nl
prefLabel
B-cell receptor triggers drug ...... ng glucosylation of ceramides.
@en
B-cell receptor triggers drug ...... ng glucosylation of ceramides.
@nl
P2093
P1433
P1476
B-cell receptor triggers drug ...... ng glucosylation of ceramides.
@en
P2093
Christian P Pallasch
Janine Schwamb
Julia Claasen
Lukas P Frenzel
Michael Baumann
Michaela Patz
Reinhild Brinker
Susanne Brodesser
Valeska Feldhaus
P304
P356
10.1182/BLOOD-2012-05-431783
P407
P577
2012-08-27T00:00:00Z